trending Market Intelligence /marketintelligence/en/news-insights/trending/a15LekC9CPqK0Flo6aK6zQ2 content esgSubNav
In This List

DBV Technologies chief medical officer resigns; interim named

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


DBV Technologies chief medical officer resigns; interim named

DBV Technologies S.A. said Lucia Septien-Velez is leaving her role as the company's chief medical officer to pursue other opportunities.

Hugh Sampson, DBV's chief scientific officer since June 2015, will now also serve as interim chief medical officer.

Paris-based DBV Technologies is developing a proprietary technology platform for use in immunotherapy.